Earnings History Data for Immuneering Corporation (IMRX) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Immuneering Corporation
Immuneering Corporation is a biopharmaceutical company advancing a pipeline of oncology and neuroscience product candidates. The company's product candidate includes IMM-1-104. Immuneering Corporation is based in CAMBRIDGE, Mass.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 01-03-2024 | PM | IMRX | Immuneering | 186.00 | -0.52 | -0.48 | 0.00 | Immuneering GAAP EPS of -$0.52 [3/1/2024 10:33 AM] |
6.11 | -0.09 (-1.45%) |
0.0 | 0.0 (0.00%) |
4.56 - 14.29 | 62,150 | 40,000 | 0 | ||
| 03-08-2023 | AH | IMRX | Immuneering | 311.00 | -0.43 | -0.54 | 0.00 | Immuneering GAAP EPS of -$0.43 beats by $0.08 [8/3/2023 6:01 PM] |
10.51 | 0.26 (2.54%) |
10.25 | 0.0 (0.00%) |
3.70 - 16.17 | 44,311 | 70,000 | 768 | ||
| 04-05-2023 | AH | After the close (May 4) |
IMRX | Immuneering | 261.00 | -0.51 | -0.54 | 0.00 | Immuneering GAAP EPS of -$0.51 beats by $0.04 [5/4/2023 6:04 PM] |
7.90 | -0.13 (-1.62%) |
7.28 | -0.75 (-9.37%) |
3.70 - 16.17 | 166,216 | 70,000 | 770 | |
| 06-03-2023 | AH | After the close (Mar 6) |
IMRX | Immuneering Corporation | 135.19 | -0.50 | -0.58 | -0.42 | Immuneering GAAP EPS of -$0.50 beats by $0.08 [3/6/2023 5:19 PM] |
5.50 | 0.31 (5.97%) |
0.0 | 0.0 (0.00%) |
3.70 - 16.17 | 22,931 | 20,000 | 0 | |
| 10-11-2022 | PM | IMRX | Immuneering | 240.00 | -0.49 | -0.48 | 0.00 | Immuneering GAAP EPS of -$0.49 in-line, revenue of $38.38M [11/10/2022 9:25 AM] |
8.71 | 0.06 (0.75%) |
0.0 | 0.0 (0.00%) |
3.74 - 30.47 | 40,800 | 40,000 | 0 | ||
|
||||||||||||||||||
| 10-08-2022 | AH | After the close (Aug 10) |
IMRX | Immuneering | 188.00 | -0.44 | -0.52 | 0.00 | 6.06 | -0.60 (-9.01%) |
0.0 | 0.0 (0.00%) |
3.74 - 33.25 | 25,634 | 20,000 | 0 | ||
| 10-05-2022 | PM | IMRX | Immuneering | 130.00 | -0.49 | -0.44 | 0.00 | Immuneering GAAP EPS of -$0.49 misses by $0.04, revenue of $0.18M in-line [5/10/2022 6:57 AM] |
4.95 | 0.66 (15.38%) |
0.0 | 0.0 (0.00%) |
4.11 - 33.99 | 93,617 | 172,048 | 0 | ||
|
||||||||||||||||||
| 10-03-2022 | PM | IMRX | Immuneering | 175.00 | -0.42 | -0.39 | 0.00 | Immuneering GAAP EPS of -$0.42, revenue of $0.19M [3/10/2022 7:02 AM] |
6.82 | -0.18 (-2.57%) |
0.0 | 0.0 (0.00%) |
0.0 - 0.0 | 19,181 | 0 | 0 | ||
| 09-11-2021 | PM | IMRX | Immuneering | 775.00 | -0.47 | -0.61 | 0.00 | Immuneering EPS beats by $0.05, beats on revenue [11/9/2021 8:57 AM] |
29.93 | -1.09 (-3.51%) |
0.0 | 0.0 (0.00%) |
16.06 - 33.99 | 63,514 | 50,000 | 0 | ||